Prospective markers in traumatic brain injury (tbi)

Abstract

The disclosure provides an in vitro prospective method for determining a recovery outcome in one or more samples of a subject having experienced traumatic brain injury (TBI), comprising the steps of a) determining the level of at least one biomarker selected from the group consisting of H-FABP, IL-10, GFAP, NF-L and S100B; and b) comparing each level obtained under step a) with a corresponding reference value to determine the recovery outcome. The disclosure also provides a device comprising an assay for determining a recovering outcome in one or more samples of a subject having experienced traumatic brain injury (TBI), the assay configured to detect a level of at least one biomarker selected from the group consisting of H-FABP, IL-10, GFAP, NF-L and S100B.

Dependencies are inferred from the claim text.